Researchers have created an AI tool that uses CT imaging to predict the spread risk of oropharyngeal cancer, offering improved treatment stratification.
Key Details
- 1Developed and validated by Mass General Brigham and Dana-Farber Cancer Institute.
- 2AI tool predicts likelihood of lymph node extranodal extension (ENE) using CT scans.
- 3Tested on imaging data from 1,733 patients with oropharyngeal carcinoma.
- 4Integration of AI assessment improved risk stratification for survival and cancer spread.
- 5Could guide both escalation and de-escalation of treatment strategies.
- 6Published in Journal of Clinical Oncology (DOI: 10.1200/JCO-24-02679).
Why It Matters
This tool offers a noninvasive approach for more accurate prognosis and tailored therapies in head and neck cancer, potentially reducing unnecessary interventions and improving outcomes. It demonstrates a significant advance in leveraging imaging AI for complex cancer management decisions.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.